Common adverse effects observed in<unk>  and vemurafenib co-treated persons in clinical trials included diarrhea, nausea, vomiting, rash, photosensitivity, and pyrexia.
Cobimetinib
Binimetinib
Selumetinib
Pralsetinib
Lestaurtinib
Nilotinib
Luspatercept
Gefitinib